Article Details
Retrieved on: 2020-11-30 21:11:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In addition, Cogent Biosciences has granted the underwriters a 30-day option to purchase up to an additional $9,000,000 of shares of its common <b>stock</b>.
Article found on: www.wfmz.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here